A High Ratio of IC31®adjuvant to Antigen Is Necessary for H4 TB Vaccine Immunomodulation

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2015.1023970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection Against Tuberculosis

Frontiers in Immunology
AllergyImmunology
2018English

L-Tyrosine Is a Promising Cancer Vaccine Adjuvant

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Influenza Virosomes Supplemented With GPI-0100 Adjuvant: A Potent Vaccine Formulation for Antigen Dose Sparing

Medical Microbiology and Immunology
MedicineAllergyImmunologyMicrobiology
2013English

Degradable Emulsion as Vaccine Adjuvant Reshapes Antigen-Specific Immunity and Thereby Ameliorates Vaccine Efficacy

Scientific Reports
Multidisciplinary
2016English

Is Adjuvant Chemotherapy Necessary for Patients With Microinvasive Breast Cancer After Surgery?

Cancer Biology and Medicine
Cancer ResearchOncology
2016English

Vaccine Adjuvant Informatics: From Data Integration and Analysis to Rational Vaccine Adjuvant Design

Frontiers in Immunology
AllergyImmunology
2014English

Development of a Virosomal RSV Vaccine Containing 3d-Phad® Adjuvant: Formulation, Composition, and Long-Term Stability

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2018English

Vaccination With Antigen Combined With Αβ-Atp as a Vaccine Adjuvant Enhances Antigen-Specific Antibody Production via Dendritic Cell Activation

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2016English

CpG DNA as a Vaccine Adjuvant

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy